Human-Centered Design in AI-Driven Clinical Decision Making

By Sumona Bose

February 6, 2024

Introduction

Artificial intelligence (AI) technologies have revolutionized the healthcare industry, particularly in the realm of clinical decision support systems (CDSS). These AI-empowered systems provide patient-specific recommendations to improve clinical work. However, alongside technical advancements, it is crucial to consider the human, social, and contextual factors that impact the successful implementation and user adoption of AI-CDSS. Human-centered design plays a pivotal role in ensuring the effectiveness and acceptance of these systems. Human centered design in AI has been an important research avenue.

The Role of AI in Clinical Decision Making

AI-empowered CDSS has shown great promise in enhancing patient evaluation and work efficiency. By analyzing vast amounts of data, AI algorithms can identify patterns and provide clinicians with valuable insights for making informed decisions. This technology has the potential to revolutionize healthcare by improving diagnostic accuracy, treatment planning, and patient outcomes.

Understanding User Needs and Experiences

To gain a comprehensive understanding of AI-CDSS, a systematic review was conducted, analyzing 20 relevant articles published between 2011 and 2022. The studies assessed various aspects of AI-CDSS, including effectiveness, user needs, user experience, and other dimensions.

The effectiveness of AI-CDSS was demonstrated through improved patient evaluation and work efficiency. Clinicians reported that AI recommendations helped them make more accurate diagnoses and develop personalized treatment plans. This technology has the potential to significantly enhance clinical decision-making processes.

User needs and experiences were also explored in the reviewed studies. Clinicians expressed the importance of having access to relevant and timely information, as well as the need for user-friendly interfaces. Additionally, factors such as satisfaction, trust, usability, workload, and understandability were found to influence the acceptance and adoption of AI-CDSS.

www.frontiersin.org
Figure 1: System features and examples.

Challenges in Implementing AI-CDSS

Despite the promising nature of AI-CDSS, the systematic review identified several challenges in implementing these systems. Technical limitations, such as algorithmic biases and data quality issues, can hinder the accuracy and reliability of AI recommendations. Workflow misalignment, attitudinal barriers, and informational barriers were also identified as challenges that impact the effective use of AI-CDSS in clinical settings.

Conclusion

The integration of artificial intelligence in clinical decision-making processes holds great potential for improving patient outcomes and work efficiency. However, the successful implementation of AI-empowered clinical decision support systems requires careful consideration of human-centered design principles and addressing the challenges identified in this study. By prioritizing user needs and experiences, healthcare professionals can harness the full benefits of AI technology in healthcare.

Reference url

Recent Posts

HIV prevention injection
   

FDA Approval and Access Strategy for Lenacapavir (Yeztugo) Long-Acting HIV Prevention

🌍 Will Yeztugo Approval and Access Strategy Deliver an Inflection Point in HIV/AIDS?

Yeztugo (lenacapavir), a twice-yearly injection, redefines long-acting HIV prevention with 96–100% efficacy. Gilead’s access strategy—insurance, assistance, and generics for 120 countries—targets global impact. Can it balance $28,218 U.S. costs with equity for 1.3M annual infections? My article explores health economics, public health, and market dynamics.

📖 Read how Yeztugo’s access strategy could transform long-acting HIV prevention

#SyenzaNews #GlobalHealth #HIVPrevention #Yeztugo #PrEP

essential prescription drugs
       

Canada Launches Consultation for Essential Prescription Drugs List

💊 Are you curious about how Canada plans to make essential prescription drugs accessible for everyone?

Canada’s Drug Agency has launched a national consultation to create a list of essential prescriptions that aim to ensure equitable access, improve health outcomes, and reduce costs. This initiative marks a key step towards universal pharmacare and highlights the importance of evidence-based practices in healthcare.

Dive into our latest article to learn more about the implications for patients, policymakers, and the broader healthcare system!

#SyenzaNews #healthcare #HealthEconomics

ACIP vaccine policy concerns
     

ACIP Vaccine Policy Concerns

🛑 Is the future of vaccine policy at risk?

The recent overhaul of the US Advisory Committee on Immunization Practices (ACIP) raises critical concerns about the integrity and transparency in vaccine recommendations. The abrupt removal of longstanding members may disrupt the essential processes that have historically upheld public trust and immunization success.

Curious about the implications for health policy and public health? Dive into the full analysis to understand the balance needed between continuity and reform!

#SyenzaNews #HealthcarePolicy #HealthEconomics #Innovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.